跳至主要内容
临床试验/NCT01164618
NCT01164618Unknown2 期

The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response

The Hospital for Sick Children2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2010年5月最近更新:
适应症
干预措施

试验速览

阶段
2 期
入组人数
12
试验地点
2
主要终点
Ischemia-reperfusion injury tolerance

研究概览

简要总结

The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans

详细描述

Remote ischemic preconditioning (RIPC) results in a powerful and widespread protective effect against subsequent prolonged ischemia-reperfusion (IR) injury of distant organs and systemic inflammatory responses, both of which are key elements in the evolution of local and multiorgan effects of many clinical IR syndromes. The signal transduction within the target organ to generate ischemia tolerance, and the effects of RIPC on systemic anti-inflammatory pathways, however, remain to be elucidated fully. Particularly, data regarding the mechanisms of 'second window' protection (a resurgence of protection 24-72 hrs after the initial RIPC stimulus) is scant; even less is known of the effects of repeated RIPC, and a potential 'third window' of protection. Our preliminary data and several recent publications have shown that the biology of RIPC and exercise show considerable overlap. This research has raised the possibility of a reciprocal effect between RIPC and exercise, with chronic exercise being a model of the potential effects of 'chronic preconditioning'. This is relevant, as repeated RIPC might be a strategy to improve exercise function in those with limited exercise tolerance e.g. heart failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years,
  • Informed consent

排除标准

  • Contraindication to exercise,
  • Vigorous aerobic/anaerobic exercise in duration of ≥15 minutes during the 21 days prior to commencement of the study, or either of the RIPC or exercise protocol arms,
  • Overt viral or bacterial infection in the 10 days prior to commencement of the study, or during either of the RIPC or exercise protocol arms,
  • Alcohol and/or caffeine consumption in the 10 days prior to, or at any time during the study period

研究组 & 干预措施

Group 1

Experimental

The subjects in this arm will begin on the daily remote ischemic preconditioning (RIPC) protocol for 10 days. After a 21 day washout period they will then crossover to 10 days of daily exercise.

干预措施: Remote ischemic preconditioning (RIPC) (Procedure)

Group 1

Experimental

The subjects in this arm will begin on the daily remote ischemic preconditioning (RIPC) protocol for 10 days. After a 21 day washout period they will then crossover to 10 days of daily exercise.

干预措施: Exercise (Other)

Group 2

Experimental

The subjects in this arm will begin on the exercise protocol for 10 days. After a 21 day washout period they will then crossover to 10 days of daily remote ischemic preconditioning (RIPC).

干预措施: Remote ischemic preconditioning (RIPC) (Procedure)

Group 2

Experimental

The subjects in this arm will begin on the exercise protocol for 10 days. After a 21 day washout period they will then crossover to 10 days of daily remote ischemic preconditioning (RIPC).

干预措施: Exercise (Other)

结局指标

主要结局

Ischemia-reperfusion injury tolerance

时间窗: Day 10 of the RIPC intervention

This will be done to assess whether chronic preconditioning in humans generates a circulating effector(s) responsible for the generation of cardioprotection in our mouse model of ischemia-reperfusion injury. This measure will be compared over time within groups and between groups.

次要结局

  • Change in skeletal muscle metabolic parameters metabolism as measured by 31P-MRS and BOLD fMRI over time within groups and between groups(Days 1, 2 and 10 days of each intervention (RIPC and Excercise))
  • Neutrophil Function - adhesion, phagocytotic index, and superoxide production over time within groups and between groups(Days 1, 2 and 10 of each intervention (RIPC and Excercise))
  • Exercise Capacity (VO2max) over time within groups and between groups(Day 10 of each intervention (RIPC and Exercise))
  • Neutrophil Gene Expression over time within groups and between groups(Days 1, 2 and 10 of each intervention (RIPC and Excercise))
  • Ischemia-reperfusion injury tolerance(Days 1, 2 and 10 of each intervention (RIPC and Excercise))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrew Redington

Head, Heart Centre-Cardiology Division

The Hospital for Sick Children

研究点 (2)

Loading locations...

相似试验

The Biology of Chronic Preconditioning: Genomic and... | 临床试验